Syringeable immunotherapeutic nanogel reshapes tumor microenvironment and prevents tumor metastasis and recurrence
The limited efficacy of current immunotherapy suggests low antigen-specific T cells and immunosuppressive factors in tumor microenvironment (TME). Here, the authors develop a syringeable immunomodulatory multi-domain nanogel that can reprogram the TME and induce enhanced cancer immunotherapy.
Guardado en:
Autores principales: | Chanyoung Song, Hathaichanok Phuengkham, Young Seob Kim, Van Vuong Dinh, Inho Lee, Il Woo Shin, Hong Sik Shin, Seung Mo Jin, Soong Ho Um, Hyunseung Lee, Kwan Soo Hong, Seon-Mi Jin, Eunji Lee, Tae Heung Kang, Yeong-Min Park, Yong Taik Lim |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2019
|
Materias: | |
Acceso en línea: | https://doaj.org/article/74f56ede70494663b8680f81b8197124 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Epigenomics and immunotherapeutic advances in pediatric brain tumors
por: Malak Abedalthagafi, et al.
Publicado: (2021) -
Implantable optical fibers for immunotherapeutics delivery and tumor impedance measurement
por: Ai Lin Chin, et al.
Publicado: (2021) -
Anti-Tumor Activity and Immunotherapeutic Potential of a Bisphosphonate Prodrug
por: Yoshimasa Tanaka, et al.
Publicado: (2017) -
Insights into tertiary lymphoid structures in the solid tumor microenvironment: anti-tumor mechanism, functional regulation, and immunotherapeutic strategies
por: Hua Zhao, et al.
Publicado: (2021) -
Deep learning model enables the discovery of a novel immunotherapeutic agent regulating the kynurenine pathway
por: Jeong Hun Kim, et al.
Publicado: (2021)